Bertino JR - Search Results

1

Plitidepsin (Aplidin) is a potent inhibitor of diffuse large cell and Burkitt lymphoma and is synergistic with rituximab.

Barboza NM, Medina DJ, Budak-Alpdogan T, Aracil M, Jimeno JM, Bertino JR, Banerjee D. Barboza NM, et al. Among authors: bertino jr. Cancer Biol Ther. 2012 Jan 15;13(2):114-22. doi: 10.4161/cbt.13.2.18876. Cancer Biol Ther. 2012. PMID: 22336911 Free PMC article.

2

Hematopoietic stem cell gene therapy with drug resistance genes: an update.

Budak-Alpdogan T, Banerjee D, Bertino JR. Budak-Alpdogan T, et al. Among authors: bertino jr. Cancer Gene Ther. 2005 Nov;12(11):849-63. doi: 10.1038/sj.cgt.7700866. Cancer Gene Ther. 2005. PMID: 16037821 Review.

3

Retinoblastoma tumor suppressor gene expression determines the response to sequential flavopiridol and doxorubicin treatment in small-cell lung carcinoma.

Budak-Alpdogan T, Chen B, Warrier A, Medina DJ, Moore D, Bertino JR. Budak-Alpdogan T, et al. Among authors: bertino jr. Clin Cancer Res. 2009 Feb 15;15(4):1232-40. doi: 10.1158/1078-0432.CCR-08-0810. Epub 2009 Jan 27. Clin Cancer Res. 2009. PMID: 19174488

4

Antitumor and modeling studies of a penetratin-peptide that targets E2F-1 in small cell lung cancer.

Xie X, Kerrigan JE, Minko T, Garbuzenko O, Lee KC, Scarborough A, Abali EE, Budak-Alpdogan T, Johnson-Farley N, Banerjee D, Scotto KW, Bertino JR. Xie X, et al. Among authors: bertino jr. Cancer Biol Ther. 2013 Aug;14(8):742-51. doi: 10.4161/cbt.25184. Epub 2013 Jun 3. Cancer Biol Ther. 2013. PMID: 23792570 Free PMC article.

5

Aplidin synergizes with cytosine arabinoside: functional relevance of mitochondria in Aplidin-induced cytotoxicity.

Humeniuk R, Menon LG, Mishra PJ, Saydam G, Longo-Sorbello GS, Elisseyeff Y, Lewis LD, Aracil M, Jimeno J, Bertino JR, Banerjee D. Humeniuk R, et al. Among authors: bertino jr. Leukemia. 2007 Dec;21(12):2399-405. doi: 10.1038/sj.leu.2404911. Epub 2007 Aug 23. Leukemia. 2007. PMID: 17713546

6

Methotrexate and cytarabine inhibit progression of human lymphoma in NOD/SCID mice carrying a mutant dihydrofolate reductase and cytidine deaminase fusion gene.

Budak-Alpdogan T, Alpdogan O, Banerjee D, Wang E, Moore MA, Bertino JR. Budak-Alpdogan T, et al. Among authors: bertino jr. Mol Ther. 2004 Sep;10(3):574-84. doi: 10.1016/j.ymthe.2004.06.115. Mol Ther. 2004. PMID: 15336657 Free article.

7

Role of pemetrexed in non-small cell lung cancer.

Longo-Sorbello GS, Chen B, Budak-Alpdogan T, Bertino JR. Longo-Sorbello GS, et al. Among authors: bertino jr. Cancer Invest. 2007 Feb;25(1):59-66. doi: 10.1080/07357900601130748. Cancer Invest. 2007. PMID: 17364559 Review.

8

Epigenetic reversal of acquired resistance to 5-fluorouracil treatment.

Humeniuk R, Mishra PJ, Bertino JR, Banerjee D. Humeniuk R, et al. Among authors: bertino jr. Mol Cancer Ther. 2009 May;8(5):1045-54. doi: 10.1158/1535-7163.MCT-08-0717. Epub 2009 Apr 21. Mol Cancer Ther. 2009. PMID: 19383845

9

Chemoprotection by transfer of resistance genes.

Budak-Alpdogan T, Bertino JR. Budak-Alpdogan T, et al. Among authors: bertino jr. Methods Mol Biol. 2009;542:661-704. doi: 10.1007/978-1-59745-561-9_34. Methods Mol Biol. 2009. PMID: 19565927

10

A second target of benzamide riboside: dihydrofolate reductase.

Roussel B, Johnson-Farley N, Kerrigan JE, Scotto KW, Banerjee D, Felczak K, Pankiewicz KW, Gounder M, Lin H, Abali EE, Bertino JR. Roussel B, et al. Among authors: bertino jr. Cancer Biol Ther. 2012 Nov;13(13):1290-8. doi: 10.4161/cbt.21786. Epub 2012 Sep 6. Cancer Biol Ther. 2012. PMID: 22954684 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

711 results

Search Page